Catalyst Wire Dossier Catalyst Wire Dossier

5-ALA HCl (5-aminolevulinic acid hydrochloride)

5-aminolevulinic acid hydrochloride
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for 5-ALA HCl (5-aminolevulinic acid hydrochloride), covering 2025-05-13 to 2025-05-13. Get the full timeline:

Most recent: Clinical Trial Update: Phase III Clinical Trial Evaluating the Resection Efficacy of 5-Aminolevulinic Acid Hydrochloride (5-ALA HCl) Fluorescence-Guided Microsurgery Versus Conventional White Light Microsurgery in Patients With Malignant Glioma (WHO Grade 3/4) [Phase 3]

See pricing